0001950047-23-002742.txt : 20230803 0001950047-23-002742.hdr.sgml : 20230803 20230803161128 ACCESSION NUMBER: 0001950047-23-002742 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230803 DATE AS OF CHANGE: 20230803 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PLIANT THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001746473 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474272481 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39303 FILM NUMBER: 231140079 BUSINESS ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-481-6770 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Hull Hans CENTRAL INDEX KEY: 0001614876 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AVALANCHE BIOTECHNOLOGIES, INC. STREET 2: 1035 O'BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 144 1 primary_doc.xml 144 0001614876 XXXXXXXX LIVE 0001746473 PLIANT THERAPEUTICS INC 001-39303 260 Littlefield Avenue South San Francisco CA 94080 6504816790 JOHANNES P HULL Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

34919 659969.10 59156444 08/03/2023 NASDAQ Common 08/03/2023 Exercise of Stock Options Issuer N 10591 08/03/2023 Cash Common 02/26/2021 Employee Stock Purchase Plan Issuer N 2419 02/26/2021 Cash Common 07/28/2022 Performance Stock Units Issuer N 8830 07/28/2022 N/A Common 05/26/2021 Restricted Stock Units Issuer N 13079 05/26/2021 N/A Y 08/03/2023 04/03/2023 /s/ Johannes Hull